leon-nanodrugs GmbH and Bionpharma Inc. said yesterday that the 2 groups inked a deal to develop a dermatological product using leon-nanodrugs’ microjet reactor nanotechnology platform.
The companies will share the development of the undisclosed product. Development will be done at leon-nanodrugs’ U.S.-based formulation partner CoreRx in Clearwater, Florida. Bionpharma will market and distribute the product in the U.S. and other markets.
Get the full story at our sister site, Drug Delivery Business News.
The post leon-nanodrugs, Bionpharma to develop microjet reactor-based dermatological product appeared first on MassDevice.